{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T15:37:31Z","timestamp":1778254651719,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T00:00:00Z","timestamp":1653264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T00:00:00Z","timestamp":1653264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Natural Science Foundation of Guangxi","award":["NO.8186110284"],"award-info":[{"award-number":["NO.8186110284"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Systemic inflammatory response (SIR) plays a crucial role in every step of tumorigenesis and development. More recently, the fibrinogen-to-albumin ratio (FAR), an inflammation-based model, was suggested as a prognostic maker for various cancer patients. This research aimed to estimate the prognostic abilities of FAR, neutrophil\u2013lymphocyte ratio (NLR), monocyte-lymphocyte ratio (MLR), platelet\u2013 lymphocyte ratio (PLR), and systemic immune\u2013inflammation index (SII) in patients with hepatocellular carcinoma (HCC) subjected to curative hepatectomy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 1,502 cases who underwent hepatectomy for HCC were included. The predictive performances of FAR, NLR, MLR, PLR and SII were assessed with regards to overall survival (OS) and disease-free survival (DFS). The area under the time-dependent receiver operating characteristic curve was used to compare prognostic performances.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Data revealed that FAR had higher predictive accuracy than other inflammation-based models and alpha-fetoprotein (AFP) in assessing OS and DFS. Indeed, the OS and DFS of patients with high FAR (&gt;\u20098.9), differentiated by the optimal cut-off value of FAR, were remarkably reduced (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05 for OS and DFS). Multivariate Cox regression analyses identified that AFP, FAR, clinically significant portal hypertension, tumor size, Barcelona Clinical Liver Cancer staging system, major resection and blood loss were independent indicators for predicting OS and DFS. Furthermore, these patients could be classified according to their FAR into significantly different subgroups, regardless of AFP levels (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05 for DFS and OS). Similar results were obtained in other inflammation-based prognostic models.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Compared with NLR, MLR, PLR, SII and AFP, FAR showed significant advantages in predicting survival of HCC patients subjected to liver resection.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12876-022-02328-4","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T16:06:42Z","timestamp":1653322002000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Preoperative fibrinogen-to-albumin ratio predicts the prognosis of patients with hepatocellular carcinoma subjected to hepatectomy"],"prefix":"10.1186","volume":"22","author":[{"given":"Rong-yun","family":"Mai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-ling","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-bin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,23]]},"reference":[{"key":"2328_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.acr.2020.10.001","volume":"149","author":"S Chidambaranathan-Reghupaty","year":"2021","unstructured":"Chidambaranathan-Reghupaty S, Fisher PB, Sarkar D. Hepatocellular carcinoma (HCC): epidemiology, etiology and molecular classification. Adv Cancer Res. 2021;149:1\u201361.","journal-title":"Adv Cancer Res"},{"issue":"1","key":"2328_CR2","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/hep.29086","volume":"67","author":"JK Heimbach","year":"2018","unstructured":"Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, Roberts LR, Zhu AX, Murad MH, Marrero JA. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1):358\u201380.","journal-title":"Hepatology"},{"issue":"1","key":"2328_CR3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","volume":"69","author":"EASL Clinical Practice Guidelines","year":"2018","unstructured":"EASL Clinical Practice Guidelines. Management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182\u2013236.","journal-title":"J Hepatol"},{"issue":"7203","key":"2328_CR4","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436\u201344.","journal-title":"Nature"},{"issue":"11","key":"2328_CR5","doi-asserted-by":"publisher","first-page":"e493","DOI":"10.1016\/S1470-2045(14)70263-3","volume":"15","author":"CI Diakos","year":"2014","unstructured":"Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15(11):e493-503.","journal-title":"Lancet Oncol"},{"issue":"1","key":"2328_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","volume":"51","author":"FR Greten","year":"2019","unstructured":"Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity. 2019;51(1):27\u201341.","journal-title":"Immunity"},{"issue":"3","key":"2328_CR7","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/j.1440-1746.2011.06910.x","volume":"27","author":"TM Chen","year":"2012","unstructured":"Chen TM, Lin CC, Huang PT, Wen CF. Neutrophil-to-lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation. J Gastroenterol Hepatol. 2012;27(3):553\u201361.","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"2328_CR8","first-page":"280","volume":"10","author":"NA Cannon","year":"2015","unstructured":"Cannon NA, Meyer J, Iyengar P, Ahn C, Westover KD, Choy H, Timmerman R. Neutrophil-lymphocyte and platelet-lymphocyte ratios as prognostic factors after stereotactic radiation therapy for early-stage non-small-cell lung cancer. J Thoracic Oncol Offl Publ Int Assoc Study Lung Cancer. 2015;10(2):280\u20135.","journal-title":"J Thoracic Oncol Offl Publ Int Assoc Study Lung Cancer"},{"issue":"2","key":"2328_CR9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/SLA.0b013e318297ad6b","volume":"258","author":"Y Mano","year":"2013","unstructured":"Mano Y, Shirabe K, Yamashita Y, Harimoto N, Tsujita E, Takeishi K, Aishima S, Ikegami T, Yoshizumi T, Yamanaka T, Maehara Y. Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis. Ann Surg. 2013;258(2):301\u20135.","journal-title":"Ann Surg"},{"issue":"1","key":"2328_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/jso.25290","volume":"119","author":"F Cananzi","year":"2019","unstructured":"Cananzi F, Minerva EM, Sam\u00e0 L, Ruspi L, Sicoli F, Conti L, Fumagalli Romario U, Quagliuolo VL. Preoperative monocyte-to-lymphocyte ratio predicts recurrence in gastrointestinal stromal tumors. J Surg Oncol. 2019;119(1):12\u201320.","journal-title":"J Surg Oncol"},{"key":"2328_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cca.2019.11.021","volume":"503","author":"M Zhang","year":"2020","unstructured":"Zhang M, Wang K, Zheng H, Zhao X, Xie S, Liu C. Monocyte lymphocyte ratio predicts the new-onset of chronic kidney disease: a cohort study. Clin Chim Acta. 2020;503:181\u20139.","journal-title":"Clin Chim Acta"},{"issue":"10","key":"2328_CR12","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1111\/hepr.12835","volume":"47","author":"T Kaida","year":"2017","unstructured":"Kaida T, Nitta H, Kitano Y, Yamamura K, Arima K, Higashi T, Taki K, Nakagawa S, Okabe H, Hayashi H, Imai K, Hashimoto D, Yamashita YI, Chikamoto A, Ishiko T, Beppu T, Baba H. Preoperative platelet-to-lymphocyte ratio can predict recurrence beyond the Milan criteria after hepatectomy for patients with hepatocellular carcinoma. Hepatol Res Offl J Jpn Soc Hepatol. 2017;47(10):991\u20139.","journal-title":"Hepatol Res Offl J Jpn Soc Hepatol"},{"issue":"10","key":"2328_CR13","doi-asserted-by":"publisher","first-page":"5663","DOI":"10.1007\/s00330-020-06931-5","volume":"30","author":"IT Schobert","year":"2020","unstructured":"Schobert IT, Savic LJ, Chapiro J, et al. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of tumor response in hepatocellular carcinoma after DEB-TACE. Eur Radiol. 2020;30(10):5663\u201373.","journal-title":"Eur Radiol"},{"issue":"23","key":"2328_CR14","doi-asserted-by":"publisher","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-14-0442","volume":"20","author":"B Hu","year":"2014","unstructured":"Hu B, Yang XR, Xu Y, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20(23):6212\u201322.","journal-title":"Clin Cancer Res"},{"issue":"34","key":"2328_CR15","doi-asserted-by":"publisher","first-page":"6261","DOI":"10.3748\/wjg.v23.i34.6261","volume":"23","author":"JH Chen","year":"2017","unstructured":"Chen JH, Zhai ET, Yuan YJ, Wu KM, Xu JB, Peng JJ, Chen CQ, He YL, Cai SR. Systemic immune-inflammation index for predicting prognosis of colorectal cancer. World J Gastroenterol. 2017;23(34):6261\u201372.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"2328_CR16","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/ejcn.2015.210","volume":"70","author":"M van Dijk","year":"2016","unstructured":"van Dijk M, Pot GK. The effects of nutritional interventions on recurrence in survivors of colorectal adenomas and cancer: a systematic review of randomised controlled trials. Eur J Clin Nutr. 2016;70(5):566\u201373.","journal-title":"Eur J Clin Nutr"},{"issue":"8","key":"2328_CR17","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1080\/01635581.2017.1367947","volume":"69","author":"M Mantzorou","year":"2017","unstructured":"Mantzorou M, Koutelidakis A, Theocharis S, Giaginis C. Clinical value of nutritional status in cancer: what is its impact and how it affects disease progression and prognosis? Nutr Cancer. 2017;69(8):1151\u201376.","journal-title":"Nutr Cancer"},{"key":"2328_CR18","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1186\/s12935-020-01558-4","volume":"20","author":"H Zhang","year":"2020","unstructured":"Zhang H, Ren D, Jin X, Wu H. The prognostic value of modified glasgow prognostic score in pancreatic cancer: a meta-analysis. Cancer Cell Int. 2020;20:462.","journal-title":"Cancer Cell Int"},{"issue":"17","key":"2328_CR19","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1016\/j.ejca.2011.03.028","volume":"47","author":"MJ Proctor","year":"2011","unstructured":"Proctor MJ, Morrison DS, Talwar D, Balmer SM, Fletcher CD, O\u2019Reilly DSJ, Foulis AK, Horgan PG, McMillan DC. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. Eur J Cancer. 2011;47(17):2633\u201341.","journal-title":"Eur J Cancer"},{"key":"2328_CR20","doi-asserted-by":"publisher","first-page":"5255","DOI":"10.2147\/OTT.S140560","volume":"10","author":"YJ Li","year":"2017","unstructured":"Li YJ, Yao K, Lu MX, Zhang WB, Xiao C, Tu CQ. Prognostic value of the C-reactive protein to albumin ratio: a novel inflammation-based prognostic indicator in osteosarcoma. Oncol Targets Ther. 2017;10:5255\u201361.","journal-title":"Oncol Targets Ther"},{"issue":"10","key":"2328_CR21","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1634\/theoncologist.2009-0079","volume":"14","author":"S Polterauer","year":"2009","unstructured":"Polterauer S, Grimm C, Seebacher V, Concin N, Marth C, Tomovski C, Husslein H, Leipold H, Hefler-Frischmuth K, Tempfer C, Reinthaller A, Hefler L. Plasma fibrinogen levels and prognosis in patients with ovarian cancer: a multicenter study. Oncologist. 2009;14(10):979\u201385.","journal-title":"Oncologist"},{"issue":"4","key":"2328_CR22","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/bjc.2013.815","volume":"110","author":"B Ghanim","year":"2014","unstructured":"Ghanim B, Hoda MA, Klikovits T, Winter MP, Alimohammadi A, Grusch M, Dome B, Arns M, Schenk P, Jakopovic M, Samarzija M, Brcic L, Filipits M, Laszlo V, Klepetko W, Berger W, Hegedus B. Circulating fibrinogen is a prognostic and predictive biomarker in malignant pleural mesothelioma. Br J Cancer. 2014;110(4):984\u201390.","journal-title":"Br J Cancer"},{"issue":"1","key":"2328_CR23","doi-asserted-by":"publisher","first-page":"148","DOI":"10.7150\/jca.22246","volume":"9","author":"W Gan","year":"2018","unstructured":"Gan W, Yi Y, Fu Y, Huang J, Lu Z, Jing C, Fan J, Zhou J, Qiu S. Fibrinogen and C-reactive protein score is a prognostic index for patients with hepatocellular carcinoma undergoing curative resection: a prognostic nomogram study. J Cancer. 2018;9(1):148\u201356.","journal-title":"J Cancer"},{"issue":"6","key":"2328_CR24","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/sj.bjc.6605547","volume":"102","author":"V Seebacher","year":"2010","unstructured":"Seebacher V, Polterauer S, Grimm C, Husslein H, Leipold H, Hefler-Frischmuth K, Tempfer C, Reinthaller A, Hefler L. The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trial. Br J Cancer. 2010;102(6):952\u20136.","journal-title":"Br J Cancer"},{"issue":"12","key":"2328_CR25","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/1471-2407-12-330","volume":"01","author":"J Zhao","year":"2012","unstructured":"Zhao J, Zhao M, Jin B, Yu P, Hu X, Teng Y, Zhang J, Luo Y, Zhang L, Zheng S, Zhou Q, Li H, Liu Y, Qu X. Tumor response and survival in patients with advanced non-small-cell lung cancer: the predictive value of chemotherapy-induced changes in fibrinogen. BMC Cancer. 2012;01(12):330.","journal-title":"BMC Cancer"},{"issue":"6","key":"2328_CR26","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.7150\/jca.16491","volume":"8","author":"Z Tan","year":"2017","unstructured":"Tan Z, Zhang M, Han Q, et al. A novel blood tool of cancer prognosis in esophageal squamous cell carcinoma: the Fibrinogen\/Albumin Ratio. J Cancer. 2017;8(6):1025\u20139.","journal-title":"J Cancer"},{"issue":"1","key":"2328_CR27","first-page":"97","volume":"53","author":"JM Jones","year":"2006","unstructured":"Jones JM, McGonigle NC, McAnespie M, Cran GW, Graham AN. Plasma fibrinogen and serum C-reactive protein are associated with non-small cell lung cancer. Lung Cancer J Int Assoc Study Lung Cancer. 2006;53(1):97\u2013101.","journal-title":"Lung Cancer J Int Assoc Study Lung Cancer"},{"issue":"1","key":"2328_CR28","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1245\/s10434-014-3857-5","volume":"22","author":"S Matsuda","year":"2015","unstructured":"Matsuda S, Takeuchi H, Kawakubo H, Fukuda K, Nakamura R, Takahashi T, Wada N, Saikawa Y, Omori T, Kitagawa Y. Cumulative prognostic scores based on plasma fibrinogen and serum albumin levels in esophageal cancer patients treated with transthoracic esophagectomy: comparison with the Glasgow prognostic score. Ann Surg Oncol. 2015;22(1):302\u201310.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"2328_CR29","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1186\/s12885-020-07191-8","volume":"20","author":"Q An","year":"2020","unstructured":"An Q, Liu W, Yang Y, Yang B. Preoperative fibrinogen-to-albumin ratio, a potential prognostic factor for patients with stage IB-IIA cervical cancer. BMC Cancer. 2020;20(1):691.","journal-title":"BMC Cancer"},{"issue":"46","key":"2328_CR30","doi-asserted-by":"publisher","first-page":"7382","DOI":"10.3748\/wjg.v26.i46.7382","volume":"26","author":"LP Zhang","year":"2020","unstructured":"Zhang LP, Ren H, Du YX, Wang CF. Prognostic value of the preoperative fibrinogen-to-albumin ratio in pancreatic ductal adenocarcinoma patients undergoing R0 resection. World J Gastroenterol. 2020;26(46):7382\u2013404.","journal-title":"World J Gastroenterol"},{"issue":"11","key":"2328_CR31","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1245\/s10434-019-07586-3","volume":"26","author":"YY Wang","year":"2019","unstructured":"Wang YY, Liu ZZ, Xu D, Liu M, Wang K, Xing BC. Fibrinogen-albumin ratio index (FARI): a more promising inflammation-based prognostic marker for patients undergoing hepatectomy for colorectal liver metastases. Ann Surg Oncol. 2019;26(11):3682\u201392.","journal-title":"Ann Surg Oncol."},{"key":"2328_CR32","first-page":"4925498","volume":"2018","author":"Q Xu","year":"2018","unstructured":"Xu Q, Yan Y, Gu S, et al. A novel inflammation-based prognostic score: the fibrinogen\/albumin ratio predicts prognoses of patients after curative resection for hepatocellular carcinoma. J Immunol Res. 2018;2018:4925498.","journal-title":"J Immunol Res"},{"issue":"4","key":"2328_CR33","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1053\/j.gastro.2015.12.041","volume":"150","author":"J Bruix","year":"2016","unstructured":"Bruix J, Reig M, Sherman M. Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology. 2016;150(4):835\u201353.","journal-title":"Gastroenterology"},{"issue":"2","key":"2328_CR34","first-page":"526","volume":"61","author":"A Berzigotti","year":"2015","unstructured":"Berzigotti A, Reig M, Abraldes JG, Bosch J, Bruix J. Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis. Hepatol Offl J Am Assoc Study Liver Dis. 2015;61(2):526\u201336.","journal-title":"Hepatol Offl J Am Assoc Study Liver Dis"},{"issue":"5","key":"2328_CR35","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1080\/110241599750006686","volume":"165","author":"B Pol","year":"1999","unstructured":"Pol B, Campan P, Hardwigsen J, Botti G, Pons J, Le Treut YP. Morbidity of major hepatic resections: a 100-case prospective study. Eur J Surg. 1999;165(5):446\u201353.","journal-title":"Eur J Surg"},{"key":"2328_CR36","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.2147\/CMAR.S186114","volume":"11","author":"RY Mai","year":"2019","unstructured":"Mai RY, Ye JZ, Long ZR, Shi XM, Bai T, Chen J, Li LQ, Wu GB, Wu FX. Preoperative aspartate aminotransferase-to-platelet-ratio index as a predictor of posthepatectomy liver failure for resectable hepatocellular carcinoma. Cancer Manag Res. 2019;11:1401\u201314.","journal-title":"Cancer Manag Res"},{"issue":"3","key":"2328_CR37","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/SLA.0000000000001743","volume":"265","author":"JC Chan","year":"2017","unstructured":"Chan JC, Chan DL, Diakos CI, Engel A, Pavlakis N, Gill A, Clarke SJ. The lymphocyte-to-monocyte ratio is a superior predictor of overall survival in comparison to established biomarkers of resectable colorectal cancer. Annals Surg. 2017;265(3):539.","journal-title":"Annals Surg"},{"issue":"11","key":"2328_CR38","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1177\/0962280217702416","volume":"27","author":"F Le Borgne","year":"2018","unstructured":"Le Borgne F, Combescure C, Gillaizeau F, Giral M, Chapal M, Giraudeau B, Foucher Y. Standardized and weighted time-dependent receiver operating characteristic curves to evaluate the intrinsic prognostic capacities of a marker by taking into account confounding factors. Stat Methods Med Res. 2018;27(11):3397\u2013410.","journal-title":"Stat Methods Med Res"},{"issue":"21","key":"2328_CR39","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res Offl J Am Assoc Cancer Res. 2004;10(21):7252\u20139.","journal-title":"Clin Cancer Res Offl J Am Assoc Cancer Res"},{"issue":"Suppl 2","key":"2328_CR40","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1016\/S0049-3848(14)50007-2","volume":"133","author":"O K\u00f6nigsbr\u00fcgge","year":"2014","unstructured":"K\u00f6nigsbr\u00fcgge O, Pabinger I, Ay C. Risk factors for venous thromboembolism in cancer: novel findings from the Vienna Cancer and Thrombosis Study (CATS). Thromb Res. 2014;133(Suppl 2):S39-43.","journal-title":"Thromb Res"},{"issue":"7","key":"2328_CR41","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1517\/14712598.3.7.1105","volume":"3","author":"CA Staton","year":"2003","unstructured":"Staton CA, Brown NJ, Lewis CE. The role of fibrinogen and related fragments in tumour angiogenesis and metastasis. Expert Opin Biol Ther. 2003;3(7):1105\u201320.","journal-title":"Expert Opin Biol Ther"},{"key":"2328_CR42","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1186\/s12885-016-2510-z","volume":"16","author":"X Yu","year":"2016","unstructured":"Yu X, Hu F, Yao Q, Li C, Zhang H, Xue Y. Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study. BMC Cancer. 2016;16:480.","journal-title":"BMC Cancer"},{"issue":"10","key":"2328_CR43","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.ctrv.2015.10.002","volume":"41","author":"C Perisanidis","year":"2015","unstructured":"Perisanidis C, Psyrri A, Cohen EE, et al. Prognostic role of pretreatment plasma fibrinogen in patients with solid tumors: a systematic review and meta-analysis. Cancer Treat Rev. 2015;41(10):960\u201370.","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"2328_CR44","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1159\/000471807","volume":"93","author":"E Ba\u011f\u0131rsak\u00e7\u0131","year":"2017","unstructured":"Ba\u011f\u0131rsak\u00e7\u0131 E, \u015eahin E, Atabey N, Erdal E, Guerra V, Carr BI. Role of albumin in growth inhibition in hepatocellular carcinoma. Oncology. 2017;93(2):136\u201342.","journal-title":"Oncology"},{"issue":"3","key":"2328_CR45","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.clnu.2008.03.002","volume":"27","author":"F Pacelli","year":"2008","unstructured":"Pacelli F, Bossola M, Rosa F, Tortorelli AP, Papa V, Doglietto GB. Is malnutrition still a risk factor of postoperative complications in gastric cancer surgery. Clin Nutr. 2008;27(3):398\u2013407.","journal-title":"Clin Nutr"},{"issue":"10","key":"2328_CR46","doi-asserted-by":"publisher","first-page":"3302","DOI":"10.1182\/blood.V96.10.3302","volume":"96","author":"JS Palumbo","year":"2000","unstructured":"Palumbo JS, Kombrinck KW, Drew AF, et al. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood. 2000;96(10):3302\u20139.","journal-title":"Blood"},{"issue":"4","key":"2328_CR47","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1001\/archsurg.2011.50","volume":"146","author":"CP Neal","year":"2011","unstructured":"Neal CP, Mann CD, Garcea G, Briggs CD, Dennison AR, Berry DP. Preoperative systemic inflammation and infectious complications after resection of colorectal liver metastases. Arch Surg. 2011;146(4):471\u20138.","journal-title":"Arch Surg"},{"key":"2328_CR48","doi-asserted-by":"publisher","first-page":"576205","DOI":"10.3389\/fonc.2020.576205","volume":"10","author":"Y Yang","year":"2020","unstructured":"Yang Y, Wang MC, Tian T, Huang J, Yuan SX, Liu L, Zhu P, Gu FM, Fu SY, Jiang BG, Liu FC, Pan ZY, Zhou WP. A high preoperative platelet-lymphocyte ratio is a negative predictor of survival after liver resection for hepatitis B virus-related hepatocellular carcinoma: a retrospective study. Front Oncol. 2020;10:576205.","journal-title":"Front Oncol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-022-02328-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-022-02328-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-022-02328-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T18:06:47Z","timestamp":1653329207000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-022-02328-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,23]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2328"],"URL":"https:\/\/doi.org\/10.1186\/s12876-022-02328-4","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,23]]},"assertion":[{"value":"18 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in compliance with the Helsinki Declaration and approved by the institutional Ethics Committee of Guangxi Medical University Cancer Hospital, and all patients provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"261"}}